📰 Intermountain Precision Genomic News
Intermountain Precision Genomic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Intermountain Precision Genomic. Real-time updates on events, politics, business and more.
May 24, 2024
SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven
May 23, 2024
Molecular Residual Disease study and multiple RiskScore studies among seven new datasets to be shared by Myriad and Collaborators SALT LAKE CITY, May 23, 2024 -- Myriad Genetics, Inc., , a leader...
January 19, 2024
SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced it has entered into a definitive agreement to acquire select
January 18, 2024
SALT LAKE CITY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...
January 18, 2024
By Will Feuer Myriad Genetics has agreed to buy certain assets from Intermountain Precision Genomics' laboratory business, including the Precise Tumor Test,...
April 18, 2023
The NYS certification enables the companies to offer solid tumor testing through the Precise Oncology Solutions suite in all 50 states.